Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Regular ✕HDFC Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseITIHDFC
NAV₹18.7412₹15.6450
NAV date20 Nov 202620 Nov 2026
History5.0 years4.0 years
Expense ratio2.6%2.1%
Stars★★★★★★★★★★
Growth Score68.8049.20

Returns

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
1 month+11.19%+7.59%
3 months+3.97%+1.66%
6 months+11.37%+11.28%
YTD+19.43%+6.77%
1 year+15.93%+4.91%
3 years (CAGR)+17.74%+10.77%
5 years (CAGR)+13.47%—
10 years (CAGR)——
Since launch+13.30%+11.89%

Risk

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
Volatility15.9%15.5%
Downside volatility10.3%10.5%
Sharpe0.710.28
Sortino1.090.41
Calmar1.010.56
Return / risk1.120.70
Deepest fall−18.53%−19.40%
Days to recover384234
Below its high+0.00%+0.00%

Against benchmark

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
Alpha−3.15%−0.70%
Beta0.980.92
R²84.6%90.6%
Up capture90.7%92.4%
Down capture104.0%94.3%
Tracking error6.2%4.9%
Information ratio−0.56−0.23
Treynor0.100.04

Consistency

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
Best 1-year+58.89%+38.26%
Middle 1-year+13.39%+5.55%
Worst 1-year−11.02%−7.13%
1-year periods with a loss25.6%14.6%
Middle 3-year+19.00%+11.45%
Positive months69.4%61.1%
Best day+3.48%+4.11%
Worst day−3.29%−6.25%
Worst 5% day−1.48%−1.53%
Positive days55.6%54.3%
NAVs a year247247

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundHDFC Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+13.53%+7.42%
1-year XIRR+25.62%+13.95%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth